Guidance on regulatory requirements in the context of the COVID-19 pandemic

European Commission, EMA and European medicines regulatory network have developed Q&As to provide guidance to stakeholders on adaptations to regulatory framework to address challenges arising from pandemic, with particular focus on crucial medicines for use in COVID-19 patients.


European Medicines Agency